Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma 11/19/14 Boston
BioPontis, Reborn as Nonprofit, Takes On Rare Disease Drugs 10/20/14 Raleigh Durham
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
Austin Startup Savara Wins Research Award for CF Therapy 10/17/13 Texas
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
East Coast Life Sciences Roundup: Insider Trading, Shire, Pfizer 11/23/12 Boston
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits 07/06/11 San Diego
Vertex CF Drug Shines in Late-Stage Study in Children 03/29/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug 02/23/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Eli Lilly Pays up to $380M for Alnara Pharma 07/20/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research 03/03/10 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News 08/12/09 Boston
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey 08/07/09 National
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results 05/28/09 Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News 04/01/09 Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started 03/25/09 Boston
Epix Reaches Milestone in CF Research 03/11/09 Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Page 1 of 2 next page »